Huapont Life Sciences Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
October 30, 2020 at 05:24 pm IST
Share
Huapont Life Sciences Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 7,887.624 million compared to CNY 7,494.042 million a year ago. Operating income was CNY 922.759 million compared to CNY 944.145 million a year ago. Net income was CNY 513.917 million compared to CNY 506.935 million a year ago. Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 0.26 a year ago.
HUAPONT LIFE SCIENCES CO., LTD. is a China-based company principally engaged in the research and development, manufacture and sales of pesticide chemical products. The Company operates through three segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sales of skin pharmaceuticals, antituberculous pharmaceuticals and other manufactured products. Its products include fleroxacin and ambroxol hydrochloride for injection, and lecithin-bound iodine capsules, among others. The Pesticide Chemical segment is engaged in the production and sales of pesticides and other fine chemicals, including herbicides, bactericides and insecticides, among others. The Bulk Drug segment is engaged in the research and development and manufacture of bulk drugs and medical intermediates. The Company is also engaged in the provision of travel services, the sales of tea and the provision of technical services, among others.
HUAPONT LIFE SCIENCES CO.,LTD 
